Pricing Log in Create free account
Saturday 17 October 2026 Export ZBH’s income statement to Excel — free account

Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.

95.06 0.68 +0.72%
Market cap
$18.0B
P/E
23.0×
Fwd P/E
17.7×
Dividend yield
1.01%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Zimmer Biomet Holdings, Inc. (ZBH) EBITDA

Alert me on EBITDA

Zimmer Biomet Holdings, Inc.'s EBITDA for fiscal 2025 was $2.2B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $2.3B. Over the past ten years it has ranged from $1.2B (fiscal 2015) to $2.3B (fiscal 2024); the current reading is higher than 64% of that period. Zimmer Biomet Holdings, Inc. ranks 8th of 147 Medical Devices companies by EBITDA.

EBITDA, annual

Embed this chart

Annual newest first

Period EBITDA Change
FY2025 $2.2B (3.95%)
FY2024 $2.3B 2.36%
FY2023 $2.2B 16.39%
FY2022 $1.9B 5.58%
FY2021 $1.8B 22.22%
FY2020 $1.5B (32.94%)
FY2019 $2.2B 7.78%
FY2018 $2.1B (6.36%)
FY2017 $2.2B 15.97%
FY2016 $1.9B 60.34%

Quarterly newest first

Period EBITDA Change
Jun 2026 $596.9M (7.20%)
Mar 2026 $643.2M 46.68%
Dec 2025 $438.5M (30.93%)
Sep 2025 $634.9M 11.04%
42 more quarters

Against its own ten years

Low $1.2B High $2.3B
Ten-year median $2.1B
Current reading's percentile 64

EBITDA against peers

Company EBITDA
PHG Koninklijke Philips N.V. compare $3.4B
GEHC GE HealthCare Technologies Inc. compare $3.3B
SNN Smith & Nephew SNATS, Inc. compare $2.6B
ZBH Zimmer Biomet Holdings, Inc. $2.3B
STE STERIS plc compare $1.6B
DXCM DexCom, Inc. compare $1.4B
GMED Globus Medical, Inc. compare $932.9M
PEN Penumbra, Inc. compare $204.5M
BIO.B Bio-Rad Laboratories, Inc. compare $53.1M

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on ZBH